Works matching IS 03407004 AND DT 2011 AND VI 60 AND IP 3
Results: 16
Mechanism of synergistic effect of chemotherapy and immunotherapy of cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 419, doi. 10.1007/s00262-010-0930-1
- By:
- Publication type:
- Article
A long peptide from MELOE-1 contains multiple HLA class II T cell epitopes in addition to the HLA-A*0201 epitope: an attractive candidate for melanoma vaccination.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 327, doi. 10.1007/s00262-010-0938-6
- By:
- Publication type:
- Article
In vivo activity of novel anti-ErbB2 antibody chA21 alone and with Paclitaxel or Trastuzumab in breast and ovarian cancer xenograft models.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 339, doi. 10.1007/s00262-010-0937-7
- By:
- Publication type:
- Article
Adoptive cell therapy of prostate cancer using female mice-derived T cells that react with prostate antigens.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 349, doi. 10.1007/s00262-010-0939-5
- By:
- Publication type:
- Article
CIMT 2010: Report on the eighth annual meeting of the association for cancer immunotherapy, May 26-28, 2010, Mainz, Germany.
- Published in:
- 2011
- By:
- Publication type:
- Report
Spontaneous and therapy-induced immunity to pluripotency genes in humans: clinical implications, opportunities and challenges.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 413, doi. 10.1007/s00262-010-0944-8
- By:
- Publication type:
- Article
Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 361, doi. 10.1007/s00262-010-0945-7
- By:
- Publication type:
- Article
Invasion and destruction of a murine fibrosarcoma by Salmonella-induced effector CD8 T cells as a therapeutic intervention against cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 371, doi. 10.1007/s00262-010-0950-x
- By:
- Publication type:
- Article
Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 381, doi. 10.1007/s00262-010-0948-4
- By:
- Publication type:
- Article
Lymphadenectomy exacerbates tumor growth while lymphadenectomy plus the adoptive transfer of autologous cytotoxic cells and low-dose cyclophosphamide induces regression of an established murine fibrosarcoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 389, doi. 10.1007/s00262-010-0949-3
- By:
- Publication type:
- Article
Determination of paraneoplastic autoimmune responses by tumor cell biology and intratumoral IFN-alpha/IL-12 in breast cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 401, doi. 10.1007/s00262-010-0956-4
- By:
- Publication type:
- Article
Immunologic biomarkers as correlates of clinical response to cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 433, doi. 10.1007/s00262-010-0960-8
- By:
- Publication type:
- Article
Suppression of T-cell responses by tumor metabolites.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 425, doi. 10.1007/s00262-010-0967-1
- By:
- Publication type:
- Article
Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 305, doi. 10.1007/s00262-011-0974-x
- By:
- Publication type:
- Article
2011: the immune hallmarks of cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 319, doi. 10.1007/s00262-010-0968-0
- By:
- Publication type:
- Article
Acknowledgement.
- Published in:
- Cancer Immunology, Immunotherapy, 2011, v. 60, n. 3, p. 451, doi. 10.1007/s00262-011-0983-9
- Publication type:
- Article